Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person The purine bases guanine and hypoxanthine (derived from aden...
| Class:Id | Summation:74260 |
|---|---|
| _displayName | The purine bases guanine and hypoxanthine (derived from aden... |
| _timestamp | 2021-04-15 21:44:20 |
| created | [InstanceEdit:74183] Jassal, B, 2003-07-17 08:31:43 |
| modified | [InstanceEdit:77415] D'Eustachio, P, 2003-10-25 14:57:00 [InstanceEdit:1442515] D'Eustachio, P, 2011-07-12 [InstanceEdit:9727352] D'Eustachio, Peter, 2021-04-15 |
| text | The purine bases guanine and hypoxanthine (derived from adenine by events in the purine salvage pathways) are converted to xanthine and then to urate uric acid, which is excreted from the body (Watts 1974). The end-point of this pathway in humans and hominoid primates is unusual. Most other mammals metabolize uric acid further to yield more soluble end products, and much speculation has centered on possible roles for high uric acid levels in normal human physiology. |
| (summation) | [Pathway:74259] Purine catabolism [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by The purine bases guanine and hypoxanthine (derived from aden... (74260)
